The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

Clinical research

Two-year clinical outcomes of paclitaxel-eluting stents for in-stent restenosis in patients from the ARRIVE programme

EuroIntervention 2011;7:314-322. DOI: 10.4244/EIJV7I3A55

1. UCLA Medical Center, Los Angeles, CA, USA; 2. Washington University School of Medicine, St. Louis, MO, USA; 3. Lehigh Valley Hospital, Allentown, PA, USA; 4. Boston Scientific Corporation, Natick, MA, USA

Aims: To examine the incidence of clinical events after implantation of the TAXUS Express paclitaxel-eluting stent (PE

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from

Read next article
Late lumen loss and intima hyperplasia after sirolimus-eluting and zotarolimus-eluting stent implantation in diabetic patients: the diabetes and drug-eluting stent (DiabeDES III) angiography and intravascular ultrasound trial